Single-dose Mass Balance Recovery and Metabolite Profile and Identification of 14C-XEN1101

NCT04952467 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xenon Pharmaceuticals Inc.